H1 Review: Cloudy with a Chance of Slowdown

“The level of bifurcation remains very high,” says Warren Hibbert. “Add to that the fact that there has been a fall in the number of deals completed and hence a sharp build-up of dry powder, it is not surprising to see the market slow down a little. There may still be a chance that funds raised in 2019 will end up exceeding the previous year, but that would be driven by a few very large closes in Q4.”

Please read the full article at Unquote

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.

Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion

We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.

Asante is excited to announce the global expansion of our secondaries business

Asante is excited to announce that Director Sam Cantor is relocating to our New York City office, further strengthening the global expansion of our secondaries business.